Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

Decision making in prostate-specific antigen screening National Health Interview Survey, 2000.

Han PK, Coates RJ, Uhler RJ, Breen N.

Am J Prev Med. 2006 May;30(5):394-404.

PMID:
16627127
2.
3.

National evidence on the use of shared decision making in prostate-specific antigen screening.

Han PK, Kobrin S, Breen N, Joseph DA, Li J, Frosch DL, Klabunde CN.

Ann Fam Med. 2013 Jul-Aug;11(4):306-14. doi: 10.1370/afm.1539.

4.

Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study).

Hoffman RM, Couper MP, Zikmund-Fisher BJ, Levin CA, McNaughton-Collins M, Helitzer DL, VanHoewyk J, Barry MJ.

Arch Intern Med. 2009 Sep 28;169(17):1611-8. doi: 10.1001/archinternmed.2009.262.

PMID:
19786681
5.

Use of the prostate-specific antigen test among U.S. men: findings from the 2005 National Health Interview Survey.

Ross LE, Berkowitz Z, Ekwueme DU.

Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):636-44. doi: 10.1158/1055-9965.EPI-07-2709.

6.

Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?

O'Dell KJ, Volk RJ, Cass AR, Spann SJ.

J Fam Pract. 1999 Sep;48(9):682-8.

PMID:
10498074
7.

Total, free, and percent free prostate-specific antigen levels among U.S. men, 2001-04.

Lacher DA, Thompson TD, Hughes JP, Saraiya M.

Adv Data. 2006 Dec 4;(379):1-12.

PMID:
17348177
8.

Physician-patient discussions with african american men about prostate cancer screening.

Ross LE, Powe BD, Taylor YJ, Howard DL.

Am J Mens Health. 2008 Jun;2(2):156-64. doi: 10.1177/1557988307309323.

PMID:
19477779
9.

Factors associated with men's use of prostate-specific antigen screening: evidence from Health Information National Trends Survey.

Finney Rutten LJ, Meissner HI, Breen N, Vernon SW, Rimer BK.

Prev Med. 2005 Apr;40(4):461-8.

PMID:
15530599
10.

The impact of informed consent on patient interest in prostate-specific antigen screening.

Wolf AM, Nasser JF, Wolf AM, Schorling JB.

Arch Intern Med. 1996 Jun 24;156(12):1333-6.

PMID:
8651843
11.

Predictors of prostate cancer screening among health fair participants.

Chiu BC, Anderson JR, Corbin D.

Public Health. 2005 Aug;119(8):686-93.

PMID:
15949522
12.

Prostate-specific antigen test use reported in the 2000 National Health Interview Survey.

Ross LE, Coates RJ, Breen N, Uhler RJ, Potosky AL, Blackman D.

Prev Med. 2004 Jun;38(6):732-44.

PMID:
15193893
13.

A population-based survey of prostate-specific antigen testing among California men at higher risk for prostate carcinoma.

Spencer BA, Babey SH, Etzioni DA, Ponce NA, Brown ER, Yu H, Chawla N, Litwin MS.

Cancer. 2006 Feb 15;106(4):765-74.

14.

Correlates of prostate-specific antigen testing in a large multiethnic cohort.

Haque R, Van Den Eeden SK, Jacobsen SJ, Caan B, Avila CC, Slezak J, Sternfeld B, Loo RK, Quinn VP.

Am J Manag Care. 2009 Nov;15(11):793-9.

15.

Prostate-specific antigen screening among young men in the United States.

Scales CD Jr, Antonelli J, Curtis LH, Schulman KA, Moul JW.

Cancer. 2008 Sep 15;113(6):1315-23. doi: 10.1002/cncr.23667.

16.

The importance of patient preference in the decision to screen for prostate cancer. Prostate Patient Outcomes Research Team.

Flood AB, Wennberg JE, Nease RF Jr, Fowler FJ Jr, Ding J, Hynes LM.

J Gen Intern Med. 1996 Jun;11(6):342-9.

PMID:
8803740
17.

The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.

Culp S, Porter M.

BJU Int. 2009 Nov;104(10):1457-61. doi: 10.1111/j.1464-410X.2009.08646.x.

18.

Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force.

Lin K, Lipsitz R, Miller T, Janakiraman S; U.S. Preventive Services Task Force..

Ann Intern Med. 2008 Aug 5;149(3):192-9. Review.

PMID:
18678846
19.

Trends in prostate-specific antigen testing from 1995 through 2004.

Farwell WR, Linder JA, Jha AK.

Arch Intern Med. 2007 Dec 10;167(22):2497-502.

PMID:
18071173
20.

How underlying patient beliefs can affect physician-patient communication about prostate-specific antigen testing.

Farrell MH, Murphy MA, Schneider CE.

Eff Clin Pract. 2002 May-Jun;5(3):120-9.

PMID:
12088291
Items per page

Supplemental Content

Support Center